Eli Lilly and Company has a 12 month low of $677.09 and a 12 month high of $972.53. The firm has a market cap of $731.45 billion, a P/E ratio of 62.80, a price-to-earnings-growth ratio of 1.12 and ...

Eli Lilly and Company has a 12-month low of $677.09 and a 12-month high of $972.53. The firm has a market cap of $737.27 billion, a P/E ratio of 63.30, a PEG ratio of 1.13 and a beta of 0.40.

Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year, and the investment will ...

Debt Management: Eli Lilly's debt-to-equity ratio surpasses industry norms, standing at 2.44. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

Wall Street analysts expect Eli Lilly (LLY) to post quarterly earnings of $5.61 per share in its upcoming report, which indicates a year-over-year increase of 43.1%. Revenues are expected to be ...

Below, we present a snapshot of the trends in volume and open interest for calls and puts across Eli Lilly's significant trades, within a strike price range of $470.0 to $960.0, over the past month.